CGI
GILD icon

CI Global Investments’s Gilead Sciences GILD Stock Holding History

CI Global Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$417M Buy
5,400,386
+298,802
+6% +$22.6M 6.41% 4
2018
Q2 		$361M Buy
5,101,584
+1,471,687
+41% +$104M 5.83% 6
2018
Q1 		$274M Sell
3,629,897
-48,290
-1% -$3.84M 4.71% 6
2017
Q4 		$264M Buy
3,678,187
+3,618,529
+6,065% +$275M 4.47% 9
2017
Q3 		$4.83M Buy
+59,658
New +$4.56M 0.09% 55
2015
Q2 		– Sell
-75,000
Closed -$7.36M – 158
2015
Q1 		$7.36M Sell
75,000
-165
-0.2% -$16.8K 0.16% 100
2014
Q4 		$7.08M Sell
75,165
-175,185
-70% -$18.1M 0.15% 103
2014
Q3 		$26.6M Buy
250,350
+10,100
+4% +$989K 0.6% 48
2014
Q2 		$19.9M Sell
240,250
-105,000
-30% -$8.17M 0.51% 57
2014
Q1 		$24.5M Sell
345,250
-7,610
-2% -$597K 0.65% 45
2013
Q4 		$26.5M Sell
352,860
-37,500
-10% -$2.61M 0.75% 40
2013
Q3 		$24.5M Buy
390,360
+60,360
+18% +$3.61M 0.93% 33
2013
Q2 		$16.9M Buy
+330,000
New +$17.2M 0.77% 44

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CI Global Investments's GILD Position: Q3 2018 in Review

CI Global Investments increased its Gilead Sciences (GILD) stake by 5.9% in Q3 2018, buying an estimated $22.6M and bringing the position to 5,400,386 shares worth $417M. The position accounts for 6.41% of the portfolio, ranked #4.

CI Global Investments first reported a position in GILD in Q2 2013 and has held it in 13 quarters since. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • CI Global Investments held 5,400,386 shares of Gilead Sciences worth $417M as of Q3 2018.
  • CI Global Investments bought 298,802 Gilead Sciences shares in Q3 2018, an estimated $22.6M.
  • Gilead Sciences made up 6.41% of CI Global Investments's portfolio in Q3 2018, its #4 holding.
  • CI Global Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 13 quarters since.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on CI Global Investments's 13F filing for Q3 2018, filed 9 Nov 2018.